GSA CAPITAL PARTNERS LLP - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 111 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q4 2020$359,000
+552.7%
24,578
+82.7%
0.06%
+321.4%
Q1 2020$55,000
-38.2%
13,452
-8.1%
0.01%
+16.7%
Q3 2019$89,000
-2.2%
14,632
+3.1%
0.01%
+140.0%
Q2 2018$91,000
-79.9%
14,196
-59.8%
0.01%
-79.2%
Q1 2017$452,00035,2900.02%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders